← Eichor
Study identifier: NCT03419689 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Study Looking at Biomarkers in Ovarian Cancer

Condition: Gynecologic Cancer  ·  Sponsor: University Health Network, Toronto

PhaseNA
Planned participants510
Who can joinFemale, 18 Years to no upper limit
Healthy volunteersNo

About this study

This is a sample study that will collect biological samples (blood, tumor tissue, ascites, and/or other fluids) from gynecological cancer patients for biomarker research. In addition, the results of the testing done on the samples will be given to the participant's treating physician who may use the information to guide treatment decisions.

This description comes directly from the study's public registry record.

Talk to the study team

Amit Oza, M.D.  ·  416-946-2818  ·  amit.oza@uhn.ca

Always discuss trial participation with your own doctor first.

Locations (7)

Royal Victoria Regional Health CentreBarrie, Ontario, CanadaRecruiting
Juravinski Cancer CentreHamilton, Ontario, CanadaActive Not Recruiting
Kingston Health Sciences CentreKingston, Ontario, CanadaRecruiting
London Health Sciences CentreLondon, Ontario, CanadaRecruiting
The Ottawa Hospital Cancer CentreOttawa, Ontario, CanadaRecruiting
Sunnybrook Health Sciences CentreToronto, Ontario, CanadaRecruiting
Princess Margaret Cancer CentreToronto, Ontario, CanadaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03419689